These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28366775)

  • 1. Noonan syndrome-associated SHP2 mutation differentially modulates the expression of postsynaptic receptors according to developmental maturation.
    Oh JY; Rhee S; Silva AJ; Lee YS; Kim HK
    Neurosci Lett; 2017 May; 649():41-47. PubMed ID: 28366775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Noonan syndrome-associated D61G variant of the protein tyrosine phosphatase SHP2 prevents synaptic down-scaling.
    Lu W; Ai H; Xue F; Luan Y; Zhang B
    J Biol Chem; 2020 Jul; 295(29):10023-10031. PubMed ID: 32499374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The down-regulation of tyrosine phosphatase SHP2 activity is involved in the removal of surface AMPA receptors in long term depression.
    Zhou H; Xie Y; Fang W; Du Y; Zhou J; Du L; Zhang B
    Neurosci Lett; 2022 May; 779():136636. PubMed ID: 35439551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excitatory neuron-specific SHP2-ERK signaling network regulates synaptic plasticity and memory.
    Ryu HH; Kim T; Kim JW; Kang M; Park P; Kim YG; Kim H; Ha J; Choi JE; Lee J; Lim CS; Kim CH; Kim SJ; Silva AJ; Kaang BK; Lee YS
    Sci Signal; 2019 Mar; 12(571):. PubMed ID: 30837304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory response in hematopoietic stem and progenitor cells triggered by activating SHP2 mutations evokes blood defects.
    Solman M; Blokzijl-Franke S; Piques F; Yan C; Yang Q; Strullu M; Kamel SM; Ak P; Bakkers J; Langenau DM; Cavé H; den Hertog J
    Elife; 2022 May; 11():. PubMed ID: 35535491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noonan Syndrome-Associated SHP2 Dephosphorylates GluN2B to Regulate NMDA Receptor Function.
    Levy AD; Xiao X; Shaw JE; Sudarsana Devi SP; Katrancha SM; Bennett AM; Greer CA; Howe JR; Machida K; Koleske AJ
    Cell Rep; 2018 Aug; 24(6):1523-1535. PubMed ID: 30089263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the effect of D61G mutation on SHP2 cause gain of function activity by a molecular dynamics study.
    Li HL; Ma Y; Zheng CJ; Jin WY; Liu WS; Wang RL
    J Biomol Struct Dyn; 2018 Nov; 36(14):3856-3868. PubMed ID: 29125030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A suggested role for mitochondria in Noonan syndrome.
    Lee I; Pecinova A; Pecina P; Neel BG; Araki T; Kucherlapati R; Roberts AE; Hüttemann M
    Biochim Biophys Acta; 2010 Feb; 1802(2):275-83. PubMed ID: 19835954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Src homology 2 domain-containing phosphotyrosine phosphatase 2 (Shp2) controls surface GluA1 protein in synaptic homeostasis.
    Zhang B; Lu W
    J Biol Chem; 2017 Sep; 292(37):15481-15488. PubMed ID: 28768764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic fibroblast growth factor selectively increases AMPA-receptor subunit GluR1 protein level and differentially modulates Ca2+ responses to AMPA and NMDA in hippocampal neurons.
    Cheng B; Furukawa K; O'Keefe JA; Goodman Y; Kihiko M; Fabian T; Mattson MP
    J Neurochem; 1995 Dec; 65(6):2525-36. PubMed ID: 7595547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Activity of Src Homology 2 Domain Containing Phosphotyrosine Phosphatase 2 (Shp2) Regulates Activity-dependent AMPA Receptor Trafficking.
    Zhang B; Du YL; Lu W; Yan XY; Yang Q; Yang W; Luo JH
    J Biol Chem; 2016 Sep; 291(36):18856-66. PubMed ID: 27417137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant neuronal activity-induced signaling and gene expression in a mouse model of RASopathy.
    Altmüller F; Pothula S; Annamneedi A; Nakhaei-Rad S; Montenegro-Venegas C; Pina-Fernández E; Marini C; Santos M; Schanze D; Montag D; Ahmadian MR; Stork O; Zenker M; Fejtova A
    PLoS Genet; 2017 Mar; 13(3):e1006684. PubMed ID: 28346493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SHP2 regulates GluA2 tyrosine phosphorylation required for AMPA receptor endocytosis and mGluR-LTD.
    Lee S; Kim J; Ryu HH; Jang H; Lee D; Lee S; Song JM; Lee YS; Suh YH
    Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2316819121. PubMed ID: 38657042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noonan syndrome mutation Q79R in Shp2 increases proliferation of valve primordia mesenchymal cells via extracellular signal-regulated kinase 1/2 signaling.
    Krenz M; Yutzey KE; Robbins J
    Circ Res; 2005 Oct; 97(8):813-20. PubMed ID: 16166557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SHP2 sails from physiology to pathology.
    Tajan M; de Rocca Serra A; Valet P; Edouard T; Yart A
    Eur J Med Genet; 2015 Oct; 58(10):509-25. PubMed ID: 26341048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noonan and LEOPARD syndrome Shp2 variants induce heart displacement defects in zebrafish.
    Bonetti M; Paardekooper Overman J; Tessadori F; Noël E; Bakkers J; den Hertog J
    Development; 2014 May; 141(9):1961-70. PubMed ID: 24718990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differing mechanisms for glutamate receptor aggregation on dendritic spines and shafts in cultured hippocampal neurons.
    Mi R; Tang X; Sutter R; Xu D; Worley P; O'Brien RJ
    J Neurosci; 2002 Sep; 22(17):7606-16. PubMed ID: 12196584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GluN2B-Containing NMDA Receptors Regulate AMPA Receptor Traffic through Anchoring of the Synaptic Proteasome.
    Ferreira JS; Schmidt J; Rio P; Águas R; Rooyakkers A; Li KW; Smit AB; Craig AM; Carvalho AL
    J Neurosci; 2015 Jun; 35(22):8462-79. PubMed ID: 26041915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic enhancement of excitatory synaptic transmission in layer II entorhinal neurons is dependent on D₁-like receptor-mediated signaling.
    Glovaci I; Caruana DA; Chapman CA
    Neuroscience; 2014 Jan; 258():74-83. PubMed ID: 24220689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation.
    Araki T; Mohi MG; Ismat FA; Bronson RT; Williams IR; Kutok JL; Yang W; Pao LI; Gilliland DG; Epstein JA; Neel BG
    Nat Med; 2004 Aug; 10(8):849-57. PubMed ID: 15273746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.